Table 1 Baseline characteristics of study participants
Variables | Biguanides | Sulfonylureas | p-value |
|---|---|---|---|
Sex | |||
Male | 1127 (33.8) | 1350 (47.4) | < 0.001 |
Female | 2209 (66.2) | 1497 (52.6) | |
Reason of exposure | |||
Intentional | |||
 Yes | 1828 (54.8) | 418 (14.7) | < 0.001 |
 No | 1508 (45.2) | 2429 (85.3) | |
Unintentional | |||
 Yes | 1189 (35.6) | 2010 (70.6) | < 0.001 |
 No | 2147 (64.4) | 837 (29.4) | |
Other | |||
 Yes | 64 (1.9) | 83 (2.9) | 0.01 |
 No | 3272 (98.1) | 2764 (97.1) | |
Medical outcomes | |||
Minor | |||
 Yes | 2012 (60.3) | 449 (15.8) | < 0.001 |
 No | 1324 (39.7) | 2398 (84.2) | |
Moderate | |||
 Yes | 1063 (31.9) | 2181 (76.6) | < 0.001 |
 No | 2273 (68.1) | 666 (23.4) | |
Major | |||
 Yes | 210 (6.3) | 209 (7.3) | 0.10 |
 No | 3126 (93.7) | 2638 (92.7) | |